glucose-lowering drugs

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

June 12, 2014

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes The Lancet, June 2014. RR Holman, H Sourij, RM CaliffDiabetes Trials Unit, University of Oxford, Oxford, UK; Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA 1Diabetes Trials Unit, University of Oxford, […]